- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Osteoporosis; Bone mineral density (BMD)
- Meeting Date: November 2009
- Public Summary Document (PSD) November 2009 PBAC Meeting - PDF
Zoledronic acid – November 2009
Zoledronic acid, solution for I.V. infusion, 5 mg (as monohydrate) in 100 mL, Aclasta®, (Men), November 2009
Last updated
5 March 2010